DR6 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - ACADIA Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 18.46 EUR -3%

Market Cap: €3B

A	ACADIA Pharmaceuticals Inc SWB:DR6	US
P	Pan American Silver Corp XMUN:PA2	CA
D	Deutsche Bank AG SWB:DBK	DE
F	Fagron NV SWB:4A5	BE
B	Banco Itau Chile SWB:D8S	CL
	Volvo AB F:VOL3	SE
	F3 Uranium Corp OTC:FUUFF	CA

Profitability Summary

ACADIA Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

92%

Strong 3Y Average Gross Margin

97%

Declining Gross Margin

98% > 92%

Low Operating Margin

10%

Strong 3Y Average Operating Margin

33%

Operating Margin is Increasing

-23% > 10%

Exceptional Net Margin

36%

Strong 3Y Average Net Margin

47%

Net Margin is Increasing

-20% > 36%

Healthy Free Cash Flow Margin

Strong 3Y Average Free Cash Flow Margin

19%

Free Cash Flow Margin is Increasing

-30% > 1%

Exceptional ROE

40%

Positive 3Y Average ROE

Exceptional 3Y Average ROIC

88%

ROIC is Increasing

-65% > 834%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.